NCT00313183View on ClinicalTrials.gov

A Study to Evaluate Symlin in Adolescent Subjects With Type 1 Diabetes Mellitus

PHASE2CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG

pramlintide acetate

single subcutaneous doses of 15mcg and 30mcg

Trial Locations (3)

Unknown

Research Site, Aurora

Research Site, Kansas City

Research Site, New York

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY